In this recorded webinar hosted by Oxford Nanopore Technologies, scientists from Ascend Advanced Therapies discuss how they have implemented Oxford Nanopore sequencing to advance the characterisation of recombinant adeno-associated virus (rAAV) vectors. Our approach enables high-resolution analysis of biological products, compared with legacy methods, including identity, truncation hotspots, product-related DNA impurities, and encapsidated host-cell DNA, providing actionable Read More The post Advancing rAAV Characterization with Oxford Nanopore Sequencing appeared first on Ascend .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules